instillation of medicated oil through uretharal opening in Benign Prostatic Hyperplasia

A RANDOMIZED CLINICAL STUDY TO EVALUATE THE EFFECTIVENESS OF DHANWANTARA TAILA AS UTTARA BASTI AND ORAL ADMINISTRATION IN THE MANAGEMENT OF VATASHTHEELA WITH SPECIAL REFERENCE TO BENIGN PROSTATE HYPERPLASIA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034489

Enrollment

Registered

2021-06-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Uttar Basti by Dhanvantara tail: Dhanvantara Taila Uttara Basti 30 ml oil will be instilled into the bladder under aseptic precautions on alternative days for 7 sittings Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: Subject diagnosed as Benign Prostatic Hyperplasia by clinical and investigative methods will be selected. Patients having IPSS Score 7- 20 should be included. In USG findings, patients having Prostate gland weight more than 40 gm and Residual Urine Volume above 30 ml should be included.13 In uroflometry Qmax 3- 20 ml/s should be included.

Exclusion criteria

Exclusion criteria: Patients with IPSS (International Prostate Symptom Score) above 20 (severe) Patients having other systemic pathology like Tuberculosis, Renal Failure, Uncontrolled Diabetes Mellitus And Uncontrolled Hypertension Etc.. Patients having other urinarysystem pathology like severe Urinary tract infections, Nephrolithiasis, Urethral Stricture, Prostatitis Patients suffering from Prostatic malignancy Patients having congenital deformity of urogenital tract HIV and HBsAg positive patients Patients having PSA value above normal (above 10 ng/ml )should be excluded.

Design outcomes

Primary

Measure	Time frame
Reduction in Prostate weight Reduction in PVRU (post void residual Urine) Increase in urine flowTimepoint: 14 days	—

Secondary

Measure	Time frame
Improvement in quality of life in terms of reduction in sleep disturbance Psychological satisfaction.Timepoint: 1 month	—

Countries

India

Contacts

Public ContactDr VD Mahanta

All India Institute of Ayurveda

drvyasayu@gmail.com7838957972

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026